| Literature DB >> 34548126 |
Abstract
COVID-19, the disease caused by the SARS-CoV-2 betacoronavirus, was declared a pandemic by the World Health Organization on March 11, 2020. Since then, SARS-CoV-2 has triggered a devastating global health and economic emergency. In response, a broad range of preclinical animal models have been used to identify effective therapies and vaccines. Current animal models do not express the full spectrum of human COVID-19 disease and pathology, with most exhibiting mild to moderate disease without mortality. NHPs are physiologically, genetically, and immunologically more closely related to humans than other animal species; thus, they provide a relevant model for SARS-CoV-2 investigations. This overview summarizes NHP models of SARS-CoV-2 and their role in vaccine and therapeutic development.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34548126 PMCID: PMC8594265 DOI: 10.30802/AALAS-CM-20-000119
Source DB: PubMed Journal: Comp Med ISSN: 1532-0820 Impact factor: 0.982